Immunotherapy hope for BRCA1 breast cancer patients
09 June, 2017 by Adam FloranceA collaborative study by local scientists has potentially developed a new way to treat one of the most difficult forms of breast cancer.
Texas Medical Center takes on Australian health innovators
07 June, 2017Three Australian start-up companies have just returned from a four-month stay at the Texas Medical Center (TMC) — the largest medical centre in the world.
Monash and Janssen Biotech collaborate on rheumatoid arthritis prevention
06 June, 2017Monash University has signed a multiyear research and commercialisation deal with Janssen Biotech for the early detection and prevention of rheumatoid arthritis.
Medical cannabis promising for hard-to-treat breast cancers
06 June, 2017Zelda Therapeutics has announced positive results from its ongoing preclinical research into the use of cannabinoids as anticancer agents.
Merck announces MS research scholarship
01 June, 2017Merck has announced further support for Australia's Multiple Sclerosis (MS) community with a new research scholarship to help fund neurology research at the Royal Melbourne Hospital.
Researchers discover inflammatory 'dimmer switch'
26 May, 2017 by Adam FloranceMonash University researchers have uncovered how a group of proteins perform like a 'dimmer switch', causing inflammation ranging from acute to chronic. The findings could contribute to new treatments for inflammatory diseases including type 2 diabetes, atherosclerosis, heart attack and stroke.
Australia, Japan team up for advanced cancer treatment
25 May, 2017ANSTO, the Centre for Medical Radiation Physics at the University of Wollongong and the National Institute of Radiological Sciences (NIRS), Japan, have partnered to deliver advanced cancer treatment, based on carbon ion therapy.
Preventing excessive platelet production in diabetics
23 May, 2017Researchers have uncovered a novel mechanism behind excessive platelet production present in people with diabetes, placing them at increased risk of cardiovascular complications such as heart attack and stroke.
Weeding out malaria
19 May, 2017 by Adam FloranceThe Menzies School of Health Research recommends a two-stage treatment for the notoriously difficult-to-cure Plasmodium vivax malaria, which has a similar approach to removing weeds from a garden bed.
Australian researchers make melanoma breakthrough
19 May, 2017Australian researchers have achieved a major breakthrough in the fight against advanced melanoma, giving hope to over 1800 Australians expected to die from the deadly disease this year.
Promoting next-gen cancer research
18 May, 2017Leaders from the Australian Nuclear Science and Technology Organisation (ANSTO), experts from Italy and clinicians from NSW recently met to explore how the full range of particle therapy treatments may be made available to Australians.
PharmAust secures non-cancer patent
17 May, 2017Australian-listed, clinical-stage oncology company PharmAust has secured a new patent in Australia covering the use of its lead drug for non-cancer applications, including neurodegenerative diseases, diabetes and age-related disorders.
'Tumour-trained' immune cells move from one tumour to another
16 May, 2017Scientists at Sydney's Garvan Institute of Medical Research have discovered that 'tumour-trained' immune cells — which have the potential to kill cancer cells — move from one tumour to another.
Immunotherapy may increase tumour growth in some cases
16 May, 2017Scientists have found that cancer immunotherapy, intended to boost the body's immune system in order to fight tumours, may actually be having the opposite effect in some cancers.
Avita Medical files IPR against Renovacare patent
12 May, 2017Avita Medical Limited, a regenerative medicine company focused on the treatment of wounds and skin defects, has filed an Inter Partes Review (IPR) petition against Renovacare patent.
